Stay up to date with our latest news and events.
Proteos offers baculovirus-infected insect cell (BIIC) banking for long term baculovirus storage. The main advantage of this service is rapid scale-up and/or re-initiation of recombinant protein production projects in insect cell expression systems (Sf9 or Tni PRO).
Proteos is exhibiting at the Merck Technology Symposium on November 6th and 7th. Please stop by booth #312 to learn why Proteos is an industry leader in the production of high-quality recombinant proteins and antibodies.
Proteos now offers multiple Thermal Shift Analysis assays for additional characterization of your protein or antibody product.
We are very excited to announce the addition of an online ordering portal on our website, www.proteos.com/order.
At Proteos, we understand that it is our employees that make our company special. Proteos’ scientific staff has decades of combined experience in the biotechnology and life science industries. In the upcoming months, we will be featuring staff profiles in an employee spotlight series on our blog so that you can learn a bit more about the hard-working individuals responsible for orchestrating your recombinant protein production projects. Our employee spotlight series begins with Jason Haineault.
Proteos has proudly partnered with The Michael J. Fox Foundation to provide high-quality protein reagents to support Parkinson’s disease research. In the past 9 months (September 2016 to June 2017), we have delivered protein reagents to 22 U.S. and 19 international locations in support of this research effort.
Proteos is proud to support life science research taking place around the world by supplying high-quality protein and antibody reagents to our valued customers. In just the past 3 months (April to June 2017), we have delivered proteins and antibodies to 27 U.S. and 7 international locations.
Proteos is a leader in customized recombinant antibody production offering production of full-length IgG, F(ab) and (Fab’)2 antibody fragments, and antibody fusion proteins. It is often beneficial for researchers to produce multiple antibodies simultaneously for functional screening studies. This type of production can be prohibitive at large scales due to cost constraints and at very small scales due to low production yields. Proteos provides researchers a solution with our medium-throughput antibody production service.
Proteos, Inc. and Protea Biosciences Group, Inc. announced today that they have entered into a joint co-marketing agreement. This mutual partnership allows Protea to combine Proteos' protein production capabilities alongside Protea's proprietary bioanalytical services, and allows Proteos to market and promote Protea's proprietary bioanalytical services with their custom protein production services
